2 completed, 2 unknown. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Unknown 2, Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow BCG Connaught: new trials by email Literature Review of BCG Connaught trials Research Report on BCG Connaught
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Electromotive Mitomycin-C (EMDA-MMC) in Preventing Recurrences in High-risk Non-muscle-invasive Bladder Cancer BCG instillation therapy, Sequential BCG and EMDA mitomycin C - Bladder Cancer | Phase 3 | Unknown | Turku University Hospital | 300 | 2018-10-26 | 2021-04-01 |
| Adding Mitomycin to BCG as Adjuvant Intravesical Therapy for High-risk Non-Muscle-invasive Bladder Cancer Bacillus of Calmette-Guerin (BCG), Mitomycin (MM) - Bladder Cancer | Phase 3 | Unknown | University of Sydney | 501 | 2013-07-01 | 2023-06-18 |
| The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus Calmette-Guerin on the Quality of Life in Superficial Bladder Cancer Gemcitabine 2 g, BCG Vaccine - Bladder Cancer | Phase 2 | Completed | A.O.U. Città della Salute e della Scienza | 120 | 2006-09-01 | 2025-01-30 |
| Sequential Bacillus Calmette-Guérin (BCG) and Electromotive Mitomycin-C Versus Bacillus Calmette-Guérin (BCG) Alone for High Risk Superficial Bladder Cancer bacillus Calmette-Guerin, electromotive mitomycin - Bladder Cancer | Phase 3 | Completed | University of Rome Tor Vergata | 212 | 1994-01-01 | 2011-09-28 |
Urinary Bladder Neoplasms (4) · Non-Muscle Invasive Bladder Neoplasms (1) · Recurrence (1)
A.O.U. Città della Salute e della Scienza (1) · Turku University Hospital (1) · University of Rome Tor Vergata (1) · University of Sydney (1)
Italy (2) · Australia (1) · Finland (1) · United Kingdom (1)
Dickon Hayne (1) · Paolo Gontero, Professor (1) · Savino M Di Stasi, MD, PhD (1)